Clinical Trials
2 trialsNCT04294498 2025-03-26
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
National Taiwan University Hospital
Phase 2 Active not recruiting
NCT04160897 2019-11-13
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis
Ruijin Hospital
Unknown